http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 22 Jul 2026 16:01:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Carlsmed+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+August+5%2C+2026/26801480.html <p>CARLSBAD, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=YAGjd0gUqLBsIMiOOzIfLs4S7KUTGFeZcGMnui7QTq4c4HVK-61qiYt6Ka29LmSQ-t1qx60QUtpUdaKut3MASA==" rel="nofollow" target="_blank">Carlsmed, Inc.</a> (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.</p> <p>A live webcast of the conference call will be available in the Events &amp; Presentations section of the company’s investor website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=us-ceyr3ft7tkKeYC-Gdyl2vIgif_HppruVdu3x_qXR6fd61KtsKVijYPZLkbtVd6jtvibMPKsQdKXGsVqLGGaiJVaZ_7zXI6C8NT__iTF-0i-L1KmBvMm0-Q_U4MdZVeN9fzCXrCwOQmvEFfD3x0A==" rel="nofollow" target="_blank">investors.carlsmed.com</a>. Participants may also join via http://www.streetinsider.com/Press+Releases/Carlsmed+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+August+5%2C+2026/26801480.html Wed, 22 Jul 2026 16:01:00 -0400 CARL O.50727930 http://www.streetinsider.com/Press+Releases/Carlsmed+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+August+5%2C+2026/26801480.html <p>CARLSBAD, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=YAGjd0gUqLBsIMiOOzIfLs4S7KUTGFeZcGMnui7QTq4c4HVK-61qiYt6Ka29LmSQ-t1qx60QUtpUdaKut3MASA==" rel="nofollow" target="_blank">Carlsmed, Inc.</a> (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.</p> <p>A live webcast of the conference call will be available in the Events &amp; Presentations section of the company’s investor website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=us-ceyr3ft7tkKeYC-Gdyl2vIgif_HppruVdu3x_qXR6fd61KtsKVijYPZLkbtVd6jtvibMPKsQdKXGsVqLGGaiJVaZ_7zXI6C8NT__iTF-0i-L1KmBvMm0-Q_U4MdZVeN9fzCXrCwOQmvEFfD3x0A==" rel="nofollow" target="_blank">investors.carlsmed.com</a>. Participants may also join via http://www.streetinsider.com/Press+Releases/Carlsmed+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+August+5%2C+2026/26801480.html Wed, 22 Jul 2026 16:01:00 -0400 CARL O.50727930 http://www.streetinsider.com/Globe+Newswire/Carlsmed+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+August+5%2C+2026/26801480.html <p>CARLSBAD, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=YAGjd0gUqLBsIMiOOzIfLs4S7KUTGFeZcGMnui7QTq4c4HVK-61qiYt6Ka29LmSQ-t1qx60QUtpUdaKut3MASA==" rel="nofollow" target="_blank">Carlsmed, Inc.</a> (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.</p> <p>A live webcast of the conference call will be available in the Events &amp; Presentations section of the company’s investor website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=us-ceyr3ft7tkKeYC-Gdyl2vIgif_HppruVdu3x_qXR6fd61KtsKVijYPZLkbtVd6jtvibMPKsQdKXGsVqLGGaiJVaZ_7zXI6C8NT__iTF-0i-L1KmBvMm0-Q_U4MdZVeN9fzCXrCwOQmvEFfD3x0A==" rel="nofollow" target="_blank">investors.carlsmed.com</a>. Participants may also join via http://www.streetinsider.com/Globe+Newswire/Carlsmed+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+August+5%2C+2026/26801480.html Wed, 22 Jul 2026 16:01:00 -0400 CARL O.50727930 http://www.streetinsider.com/Globe+Newswire/Carlsmed+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+August+5%2C+2026/26801480.html <p>CARLSBAD, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=YAGjd0gUqLBsIMiOOzIfLs4S7KUTGFeZcGMnui7QTq4c4HVK-61qiYt6Ka29LmSQ-t1qx60QUtpUdaKut3MASA==" rel="nofollow" target="_blank">Carlsmed, Inc.</a> (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2026 financial results after market close on Wednesday, August 5, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.</p> <p>A live webcast of the conference call will be available in the Events &amp; Presentations section of the company’s investor website at <a target="_blank" href="https://www.globenewswire.com/Tracker?data=us-ceyr3ft7tkKeYC-Gdyl2vIgif_HppruVdu3x_qXR6fd61KtsKVijYPZLkbtVd6jtvibMPKsQdKXGsVqLGGaiJVaZ_7zXI6C8NT__iTF-0i-L1KmBvMm0-Q_U4MdZVeN9fzCXrCwOQmvEFfD3x0A==" rel="nofollow" target="_blank">investors.carlsmed.com</a>. Participants may also join via http://www.streetinsider.com/Globe+Newswire/Carlsmed+Inc.+to+Report+Second+Quarter+2026+Financial+Results+on+August+5%2C+2026/26801480.html Wed, 22 Jul 2026 16:01:00 -0400 CARL O.50727930 http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html <p>Piper Sandler analyst Matt O'Brien weighs in on the spine space following the Spine Doc Survey.</p><p>The analyst commented: "We surveyed 30 spine surgeons that perform at least 75 cases annually and were very pleased to hear a high majority of them say procedure volumes have been steady the past three months and the outlook for the remainder of the year is positive too. They expect to perform more robotically-assisted cases in the future, with GMED and MDT the standouts here. Feedback on the new MDT robot was really good, which is a clear positive for them, and a number of http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html Thu, 09 Jul 2026 10:30:40 -0400 ATEC CARL GMED MDT SZK ZBH http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html <p>Piper Sandler analyst Matt O'Brien weighs in on the spine space following the Spine Doc Survey.</p><p>The analyst commented: "We surveyed 30 spine surgeons that perform at least 75 cases annually and were very pleased to hear a high majority of them say procedure volumes have been steady the past three months and the outlook for the remainder of the year is positive too. They expect to perform more robotically-assisted cases in the future, with GMED and MDT the standouts here. Feedback on the new MDT robot was really good, which is a clear positive for them, and a number of http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html Thu, 09 Jul 2026 10:30:40 -0400 ATEC CARL GMED MDT SZK ZBH http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html <p>Piper Sandler analyst Matt O'Brien weighs in on the spine space following the Spine Doc Survey.</p><p>The analyst commented: "We surveyed 30 spine surgeons that perform at least 75 cases annually and were very pleased to hear a high majority of them say procedure volumes have been steady the past three months and the outlook for the remainder of the year is positive too. They expect to perform more robotically-assisted cases in the future, with GMED and MDT the standouts here. Feedback on the new MDT robot was really good, which is a clear positive for them, and a number of http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html Thu, 09 Jul 2026 10:30:40 -0400 ATEC CARL GMED MDT SZK ZBH http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html <p>Piper Sandler analyst Matt O'Brien weighs in on the spine space following the Spine Doc Survey.</p><p>The analyst commented: "We surveyed 30 spine surgeons that perform at least 75 cases annually and were very pleased to hear a high majority of them say procedure volumes have been steady the past three months and the outlook for the remainder of the year is positive too. They expect to perform more robotically-assisted cases in the future, with GMED and MDT the standouts here. Feedback on the new MDT robot was really good, which is a clear positive for them, and a number of http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html Thu, 09 Jul 2026 10:30:40 -0400 ATEC CARL GMED MDT SZK ZBH http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html <p>Piper Sandler analyst Matt O'Brien weighs in on the spine space following the Spine Doc Survey.</p><p>The analyst commented: "We surveyed 30 spine surgeons that perform at least 75 cases annually and were very pleased to hear a high majority of them say procedure volumes have been steady the past three months and the outlook for the remainder of the year is positive too. They expect to perform more robotically-assisted cases in the future, with GMED and MDT the standouts here. Feedback on the new MDT robot was really good, which is a clear positive for them, and a number of http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html Thu, 09 Jul 2026 10:30:40 -0400 ATEC CARL GMED MDT SZK ZBH http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html <p>Piper Sandler analyst Matt O'Brien weighs in on the spine space following the Spine Doc Survey.</p><p>The analyst commented: "We surveyed 30 spine surgeons that perform at least 75 cases annually and were very pleased to hear a high majority of them say procedure volumes have been steady the past three months and the outlook for the remainder of the year is positive too. They expect to perform more robotically-assisted cases in the future, with GMED and MDT the standouts here. Feedback on the new MDT robot was really good, which is a clear positive for them, and a number of http://www.streetinsider.com/Analyst+Comments/Piper+Sandler%27s+Spine+Doc+Survey+Results%3A+%27We+favor+ATEC+and+GMED+as+our+top+picks%27/26751648.html Thu, 09 Jul 2026 10:30:40 -0400 ATEC CARL GMED MDT SZK ZBH http://www.streetinsider.com/New+Coverage/Needham+Starts+Carlsmed+Inc+%28CARL%29+at+Buy/26715905.html <p>Needham analyst David Saxon initiates coverage on Carlsmed Inc (NASDAQ: CARL) with a Buy rating and a price target of $17.00.</p><p>The analyst comments "We are initiating coverage with a Buy rating and a $17 price target as we believe CARL's personalized aprevo implants are differentiated vs. traditional stock spine implants. Given attractive clinical data showing lower revision rates to stock implants, in addition to favorable facility reimbursement, we expect CARL to see broader adoption, with our physician calls suggesting strong utilization growth. We believe this can allow CARL to sustain its high-growth profile and help it progress towards profitability."</p><p>For an http://www.streetinsider.com/New+Coverage/Needham+Starts+Carlsmed+Inc+%28CARL%29+at+Buy/26715905.html Wed, 01 Jul 2026 05:42:11 -0400 CARL http://www.streetinsider.com/Analyst+Comments/Needham+Starts+Carlsmed+Inc+%28CARL%29+at+Buy/26715905.html <p>Needham analyst David Saxon initiates coverage on Carlsmed Inc (NASDAQ: CARL) with a Buy rating and a price target of $17.00.</p><p>The analyst comments "We are initiating coverage with a Buy rating and a $17 price target as we believe CARL's personalized aprevo implants are differentiated vs. traditional stock spine implants. Given attractive clinical data showing lower revision rates to stock implants, in addition to favorable facility reimbursement, we expect CARL to see broader adoption, with our physician calls suggesting strong utilization growth. We believe this can allow CARL to sustain its high-growth profile and help it progress towards profitability."</p><p>For an http://www.streetinsider.com/Analyst+Comments/Needham+Starts+Carlsmed+Inc+%28CARL%29+at+Buy/26715905.html Wed, 01 Jul 2026 05:42:11 -0400 CARL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+OBOYLE+KEVIN+C/26669460.html si-local-file:///var/storage/secattach/20260622/26669460.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+OBOYLE+KEVIN+C/26669460.html Mon, 22 Jun 2026 06:14:00 -0400 CARL O.50727930 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+OBOYLE+KEVIN+C/26669460.html si-local-file:///var/storage/secattach/20260622/26669460.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+OBOYLE+KEVIN+C/26669460.html Mon, 22 Jun 2026 06:14:00 -0400 CARL O.50727930 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+Sidow+Kevin/26669452.html si-local-file:///var/storage/secattach/20260622/26669452.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+Sidow+Kevin/26669452.html Mon, 22 Jun 2026 06:11:00 -0400 CARL O.50727930 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+Sidow+Kevin/26669452.html si-local-file:///var/storage/secattach/20260622/26669452.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+Sidow+Kevin/26669452.html Mon, 22 Jun 2026 06:11:00 -0400 CARL O.50727930 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+YOUNG+PHILIP+M/26669363.html si-local-file:///var/storage/secattach/20260622/26669363.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+YOUNG+PHILIP+M/26669363.html Mon, 22 Jun 2026 06:03:00 -0400 CARL O.50727930 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+YOUNG+PHILIP+M/26669363.html si-local-file:///var/storage/secattach/20260622/26669363.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+YOUNG+PHILIP+M/26669363.html Mon, 22 Jun 2026 06:03:00 -0400 CARL O.50727930 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+ROOT+JONATHAN+D/26669364.html si-local-file:///var/storage/secattach/20260622/26669364.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+ROOT+JONATHAN+D/26669364.html Mon, 22 Jun 2026 06:03:00 -0400 CARL O.50727930 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+ROOT+JONATHAN+D/26669364.html si-local-file:///var/storage/secattach/20260622/26669364.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03++Filed+by%3A+ROOT+JONATHAN+D/26669364.html Mon, 22 Jun 2026 06:03:00 -0400 CARL O.50727930 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03/26598767.html si-local-file:///var/storage/secattach/20260603/26598767.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03/26598767.html Wed, 03 Jun 2026 16:06:00 -0400 CARL O.50727930 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03/26598767.html si-local-file:///var/storage/secattach/20260603/26598767.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CARLSMED%2C+INC.++++++++++++For%3A+Jun+03/26598767.html Wed, 03 Jun 2026 16:06:00 -0400 CARL O.50727930 http://www.streetinsider.com/Earnings/Carlsmed%2C+Inc.+%28CARL%29+Tops+Q1+EPS+by+5c/26436832.html <p>Carlsmed, Inc. (NASDAQ: CARL) reported Q1 EPS of ($0.32), $0.05 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $16.1 million.</p><p>For earnings history and earnings-related data on Carlsmed, Inc. (CARL) <a href="http://www.streetinsider.com/ec_earnings.php?q=CARL">click here</a>.</p> http://www.streetinsider.com/Earnings/Carlsmed%2C+Inc.+%28CARL%29+Tops+Q1+EPS+by+5c/26436832.html Tue, 05 May 2026 18:09:06 -0400 CARL http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CARLSMED%2C+INC.++++++++++++For%3A+Mar+31/26434771.html si-local-file:///var/storage/secattach/20260505/26434771.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CARLSMED%2C+INC.++++++++++++For%3A+Mar+31/26434771.html Tue, 05 May 2026 16:11:00 -0400 CARL O.50727930 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CARLSMED%2C+INC.++++++++++++For%3A+Mar+31/26434771.html si-local-file:///var/storage/secattach/20260505/26434771.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++CARLSMED%2C+INC.++++++++++++For%3A+Mar+31/26434771.html Tue, 05 May 2026 16:11:00 -0400 CARL O.50727930